Citius Pharmaceuticals, Inc. Royalty Expense
Citius Pharmaceuticals, Inc. (CTXR) reported Royalty Expense of $100.00 thousand for the 6-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2024-05-14
- Citius Pharmaceuticals, Inc. royalty expense for the quarter ending 2024-03-31 was $0.00.
- Citius Pharmaceuticals, Inc. royalty expense for the quarter ending 2023-12-31 was $100.00K, a 0.00% change year-over-year.
- Citius Pharmaceuticals, Inc. royalty expense for the quarter ending 2023-09-30 was $0.00.
- Citius Pharmaceuticals, Inc. royalty expense for the quarter ending 2023-06-30 was $0.00.
- Citius Pharmaceuticals, Inc. royalty expense for fiscal 2023 was $100.00K, a 0.00% change from fiscal 2022.
- Citius Pharmaceuticals, Inc. royalty expense for fiscal 2022 was $100.00K, a 0.00% change from fiscal 2021.
- Citius Pharmaceuticals, Inc. royalty expense for fiscal 2021 was $100.00K, a 0.00% change from fiscal 2020.
- Citius Pharmaceuticals, Inc. royalty expense for fiscal 2020 was $100.00K.
| Period end | Royalty Expense 0 month | Royalty Expense 3 month | Royalty Expense 6 month | Royalty Expense 9 month | Royalty Expense 12 month |
|---|---|---|---|---|---|
| 2024-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-14 | $100.00K 10-Q · filed 2024-05-14 | $100.00K derived: sum of 3 quarters · filed 2024-05-14 | $100.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2023-12-31 | $100.00K 10-Q · filed 2024-02-14 | $100.00K derived: sum of 2 quarters · filed 2024-02-14 | $100.00K derived: sum of 3 quarters · filed 2024-02-14 | $100.00K derived: sum of 4 quarters · filed 2024-02-14 | |
| 2023-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-29 | $0.00 derived: sum of 2 quarters · filed 2023-12-29 | $0.00 derived: sum of 3 quarters · filed 2023-12-29 | $100.00K 10-K · filed 2023-12-29 | |
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $0.00 derived: sum of 2 quarters · filed 2023-08-14 | $100.00K 10-Q · filed 2023-08-14 | $100.00K derived: sum of 4 quarters · filed 2023-08-14 | |
| 2023-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | $100.00K 10-Q · filed 2023-05-12 | $100.00K derived: sum of 3 quarters · filed 2023-05-12 | $100.00K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2022-12-31 | $100.00K 10-Q · filed 2023-02-10 | $100.00K derived: sum of 2 quarters · filed 2023-02-10 | $100.00K derived: sum of 3 quarters · filed 2023-02-10 | $100.00K derived: sum of 4 quarters · filed 2023-02-10 | |
| 2022-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $0.00 derived: sum of 2 quarters · filed 2022-12-22 | $0.00 derived: sum of 3 quarters · filed 2022-12-22 | $100.00K 10-K · filed 2022-12-22 | |
| 2022-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | $0.00 derived: sum of 2 quarters · filed 2022-08-11 | $100.00K 10-Q · filed 2022-08-11 | $100.00K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2022-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | $100.00K 10-Q · filed 2022-05-12 | $100.00K derived: sum of 3 quarters · filed 2022-05-12 | $100.00K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2021-12-31 | $100.00K 10-Q · filed 2022-02-10 | $100.00K derived: sum of 2 quarters · filed 2022-02-10 | $100.00K derived: sum of 3 quarters · filed 2022-02-10 | $100.00K derived: sum of 4 quarters · filed 2022-02-10 | |
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-15 | $0.00 derived: sum of 2 quarters · filed 2021-12-15 | $0.00 derived: sum of 3 quarters · filed 2021-12-15 | $100.00K 10-K · filed 2021-12-15 | |
| 2021-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | $0.00 derived: sum of 2 quarters · filed 2021-08-12 | $100.00K 10-Q · filed 2021-08-12 | $100.00K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2021-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-13 | $100.00K 10-Q · filed 2021-05-13 | $100.00K derived: sum of 3 quarters · filed 2021-05-13 | ||
| 2020-12-31 | $100.00K 10-Q · filed 2021-02-11 | $100.00K derived: sum of 2 quarters · filed 2021-02-11 | |||
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-16 | $100.00K 10-K · filed 2020-12-16 | |||
| 2020-06-30 | $100.00K 10-Q · filed 2020-08-14 | ||||
| 2019-01-02 | $100.00K 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |